HOME >> MEDICINE >> NEWS
FDA-approved drugs shown to lower Alzheimer diseaserelated protein levels in mice

Alzhemier disease (AD) is characterized by the progressive accumulation of amyloid b protein (Abeta) in areas of the brain serving cognitive functions such as memory and language. In 2001, Todd Golde and colleagues demonstrated that three commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) were capable of selectively lowering the levels of Abeta42 (an isoform of the Abeta protein) in mice. In the August 1 issue of the Journal of Clinical Investigation, Golde and colleagues from the Mayo Clinic in Jacksonville, Florida, extend their previous studies and report that of 20 commonly used NSAIDs, 8 FDA-approved drugs successfully lowered Abeta42 levels in mice at doses achievable in humans.

Multiple forms of Abeta42 are generated from the Abeta42 protein precursor (APP) following cleavage with enzymes known as b- and gamma-secretases. Abeta40 is the most abundant, however Abeta42 is deposited earlier and more consistently than Abeta40 and is therefore more toxic.

Of the NSAIDs tested, meclofenamic acid and flurbiprofen were the most effective at decreasing Abeta42 levels. The authors found that flurbiprofen, currently in clinical trials for the treatment of prostate and colon cancer, directly targets gamma-secretase and the conversion of APP to Abeta42 without inducing toxic gastrointestinal or renal side-effects associated with some NSAIDs.

In their accompanying commentary, Drs. John Cirrito and David Holtzman from Washington University in St. Louis, Missouri comment that "these studies provide exciting new insights and avenues for AD treatment by furthering our understanding of how NSAIDs alter Abeta42 production. While it is not going to be easy, there remains much hope that the amyloid hypothesis of AD will be tested and that truly effective therapies for AD can be developed".

TITLE: NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta42 in vivo

AUTHOR CONTACT:
Todd Golde
Mayo Clini
'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
1-Aug-2003


Page: 1 2

Related medicine news :

1. UW research shows risk factors for relapse among health care professionals who abuse drugs
2. New studies show mixed results on epilepsy drugs and birth defects
3. Newly discovered pathway might help in design of cancer drugs
4. Study examines consequences of Thailands war on drugs
5. Computational tool predicts how drugs work in cells, advancing efforts to design better medicines
6. Three anti-platelet drugs used in combination are safe
7. HIV patients may be at risk of heart problems when taking protease inhibitor drugs
8. Clot-busting drugs may help detect potentially deadly leg clots
9. Herb used to treat diabetes works like modern-day prescription drugs, study suggests
10. Penn study shows how next-generation diabetic drugs could work more selectively
11. Study shows drugs such as Vioxx and Celebrex were widely over-used long before recent problems

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... ... and topsy-turvy economic outlook continues to put financial strain on many of us, so it ... from our monthly expenses and put more into savings, if possible. , “That’s a great ... safety net in place in case something were to happen to you,” says Lee Duncan, ...
(Date:8/31/2020)... NEW HAVEN, Conn. (PRWEB) , ... August 31, ... ... a medical device intended to improve outcomes for patients with advanced heart failure, ... Innovation Research (SBIR) grant in the amount of $555,358 from the National Heart, ...
(Date:8/28/2020)... ... 28, 2020 , ... The 15 scholarships being offered by ... Wellness mobile app and web-portal. NCPCV received a 2020 grant from Motorola Solutions ... year to organizations, such as Destination Imagination, which support and advance public safety ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... that strongly suggest that obese individuals are at an increased risk of developing ... more likely to catch COVID-19; however, because the same organ systems that the ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... the upcoming Global Inclusion Online Forum, leading a session entitled, “A CEO Guide ... event of this magnitude designed to bring together the world’s leading diversity and ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... 27, 2020 , ... Trella Health, the leading source of ... cloud CRM, marketing automation, and contact center solutions for senior living communities and ... Trella’s performance intelligence data and insights into Enquire’s CRM solution to serve as ...
(Date:8/26/2020)... SAN DIEGO (PRWEB) , ... August 26, 2020 , ... ... the 2020 Infection Control Company of the Year by MedTech Outlook. , ... Operating Officer. “For the first time, clinicians who wear gloves on their hands, goggles ...
(Date:8/26/2020)... ... August 26, 2020 , ... As the U.S. struggles in its ... for preventing the Coronavirus. Wear a mask, keep your distance, wash your hands. Prevention ... Burkitt said it best in 1977, “How much better it is to prevent disease ...
Breaking Medicine Technology:
Cached News: